119 related articles for article (PubMed ID: 38735135)
1. Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells.
Ma R; Hu K; Dai S; Wang Y
Biochem Biophys Res Commun; 2024 Jul; 718():150037. PubMed ID: 38735135
[TBL] [Abstract][Full Text] [Related]
2. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
4. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
[TBL] [Abstract][Full Text] [Related]
5. YAP1/TEAD1 upregulate platelet-derived growth factor receptor beta to promote vascular smooth muscle cell proliferation and neointima formation.
Osman I; Dong K; Kang X; Yu L; Xu F; Ahmed ASI; He X; Shen J; Hu G; Zhang W; Zhou J
J Mol Cell Cardiol; 2021 Jul; 156():20-32. PubMed ID: 33753119
[TBL] [Abstract][Full Text] [Related]
6. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
Li H; Lan H; Zhang M; Zhao F; An N; Yi C
Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
9. HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway.
Zheng S; Mo J; Zhang J; Chen Y
Oncol Lett; 2023 Mar; 25(3):90. PubMed ID: 36817050
[TBL] [Abstract][Full Text] [Related]
10. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
11. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
[TBL] [Abstract][Full Text] [Related]
12. The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).
He S; Zhang H; Xiao Z; Bhushan S; Gao K; Wang W
Bioengineered; 2021 Dec; 12(1):601-614. PubMed ID: 33517828
[TBL] [Abstract][Full Text] [Related]
13. Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network.
Qu R; Ma J
Anticancer Drugs; 2023 Nov; 34(10):1151-1161. PubMed ID: 36727737
[TBL] [Abstract][Full Text] [Related]
14. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells.
Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C
J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212
[TBL] [Abstract][Full Text] [Related]
15. YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts.
Shen T; Li Y; Wang D; Su Y; Li G; Shang Z; Niu Y; Tan X
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166540. PubMed ID: 36100154
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling.
Shen Y; Li C; Zhou L; Huang JA
J Cell Mol Med; 2021 Jan; 25(1):284-296. PubMed ID: 33237585
[TBL] [Abstract][Full Text] [Related]
17. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
18. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
19. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
[TBL] [Abstract][Full Text] [Related]
20. STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma.
Lai Y; Zhang Z; Li J; Li W; Huang Z; Zhang C; Li X; Zhao J
Biochem Biophys Res Commun; 2019 Nov; 519(4):659-666. PubMed ID: 31542233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]